Malaysian pharmaceutical company, Covid Medicare Support Inc. (CMSI), which was previously announced as the liaison and sole distributor of the C-Vx – Immuno X booster vaccine (booster) to all 48 countries in Asia as well as Australia, New Zealand, Taiwan, Hong Kong, Macau, and Libya, has now added the United Arab Emirates (UAE) and other countries that resides in the middle east as part of their sole distribution domain.
Recently in March, CMSI held a Memorandum of Understanding (MoU) signing ceremony with Hortman Clinics & Acquest Laboratory, in Dubai, for the purchase of 2 million doses of the said booster, in the presence of the Prime Minister of Malaysia, YB Dato’ Sri Ismail Sabri; YB Dato’ Seri Mohamed Azmin bin Ali, Senior Minister of International Trade & Industry (MITI); YB Dato’ Sri Dr. Adham Bin Baba, Minister of Science, Technology and Innovation (MOSTI); YB Datuk Arthur Joseph Kurup, Deputy Minister of Works (KKR); and YB Dato’ Seri Mahdzir bin Khalid, Minister of Rural Development.
Upon officially documenting the appeal towards obtaining the 2 million doses, the MoU was then followed up with a sale and purchase agreement shortly after. Initiated as a cancer treatment study, the C-Vx–Immuno X booster has been redeveloped to be the multiple viral antigens for the prevention and cure of COVID-19. Throughout the past years of developing the booster, C-VX-Immuno X has been developing the perfect formula with consideration towards the latest COVID-19 variants, allowing infected individuals to recover from the virus.
The study found that a single dose of C-Vx – Immuno X that was given to the infected volunteers resulted in the absence of COVID-19 in their bodies. The booster instantly eliminates COVID-19 viruses that target the formation of the IGG antibody formation which is an anti-inflammatory antibody in uninfected individuals. According to researchers, the natural and unique combination of formulas will provide receivers immunization from COVID-19 for up to 11 months.
Interested parties may contact Dato’ Mike Loh at email@example.com for further information & queries.